Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Proteomic identification of heat shock protein 27 as a differentiation and prognostic marker in neuroblastoma but not in Ewing’s sarcomaVirchows Archiv, 2007
- Triptolide Induces Pancreatic Cancer Cell Death via Inhibition of Heat Shock Protein 70Cancer Research, 2007
- Resistance to geldanamycin-induced apoptosis in differentiated neuroblastoma SH-SY5Y cellsNeuroscience Letters, 2007
- Heat Shock Protein 70 Increases Tumorigenicity and Inhibits Apoptosis in Pancreatic AdenocarcinomaCancer Research, 2007
- Geldanamycin decreases Raf‐1 and Akt levels and induces apoptosis in neuroblastomasInternational Journal of Cancer, 2002
- Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell deathJournal of Molecular Medicine, 2001
- Neuroblastoma: Changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease RegistryMedical and Pediatric Oncology, 2001
- IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastomaCell Death & Differentiation, 2000
- Terminology and morphologic criteria of neuroblastic tumorsCancer, 1999
- Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamstersCancer Letters, 1998